Skip to main content
Cancer Explained

News

Cancer Drug Shortages This Week: What to Ask

How to use FDA drug-shortage information when a cancer medicine is hard to find, with questions for oncology teams, pharmacies, and insurers.

By Cancer Explained Editorial TeamPublished July 21, 2026

Original commentary from the Cancer Explained editorial team.

Cancer Explained visual summary for this story.

Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.

In brief

FDA maintains a public drug-shortage database and explains that shortages are evaluated at the national level. Local pharmacy access problems can happen even when a medicine is not officially in national shortage.

What changed this week

This article is a recurring patient-question format, not a claim that a specific cancer drug is newly unavailable. The practical task this week is to make sure patients and caregivers know how to ask about supply, alternatives, timing, and documentation when a drug is delayed.

What this does not mean

  • It does not mean every local access problem is an FDA-defined national shortage.
  • It does not mean a patient should switch, skip, split, or stretch medicine without the oncology team.
  • It does not mean FDA can tell an individual patient which alternative is best.

Source table

SourceWhat it can tell youWhat it cannot decide for you
FDA drug shortages pageWhether FDA lists a product as current, resolved, or discontinuedWhether a local pharmacy can get supply today
FDA FAQHow FDA defines shortages and why alternatives are not listed for individual patientsWhich substitute is safe for one person's cancer and treatment plan
Oncology team or specialty pharmacyWhether timing, dose, alternative drug, prior authorization, or a different pharmacy mattersA national shortage determination

Questions patients can ask

  • Is my medicine actually unavailable, delayed, substituted, or waiting for insurance approval?
  • Is this a local supply issue or an FDA-listed national shortage?
  • What is the safest backup plan if the drug is not available by the treatment date?
  • Who is coordinating the prescriber, infusion center, specialty pharmacy, and insurer?
  • What should be documented in my chart if treatment timing changes?

How this article was prepared

Prepared by Cancer Explained's AI-assisted editorial system and checked against the official FDA sources listed below. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown.

Found an error, a broken source link, outdated information, or wording that feels unsafe or unclear? Report it here.

💛 Support free cancer education

Cancer Explained is free for everyone. Donations help us keep creating calm, plain-language explanations based on trusted National Cancer Institute resources.